EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Accounting for differences between Infinium MethylationEPIC v2 and v1 in DNA methylation–based tools

Beryl C Zhuang, Marcia Smiti Jude, Chaini Konwar iD, Natan Yusupov, Calen P Ryan iD, Hannah-Ruth Engelbrecht, Joanne Whitehead iD, Alexandra A Halberstam, Julia L MacIsaac, Kristy Dever, Toan Khanh Tran iD, Kim Korinek iD und 10 weitere

Life Science Alliance · 2025-09 · 8 (9) · e202403155

DOI: 10.26508/lsa.202403155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 08.07.2025. Verfasst von Beryl C Zhuang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Edwin S. H. Leong Centre for Healthy Aging, Faculty of Medicine, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: DNA Methylation, Epigenomics. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, Canadian Government | Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recently launched Illumina Infinium MethylationEPIC v2.0 (EPICv2), successor of MethylationEPIC v1.0 (EPICv1), retains most of the probes in EPICv1, while expanding coverage of regulatory elements. The concordance between the two EPIC versions in DNA methylation–based tools has not yet been investigated. To address this, DNA methylation was profiled on both versions using matched blood samples across four cohorts spanning early to late adulthood. High concordance between versions at the array level but variable agreement at the individual probe level was noted. A significant contribution of the EPIC version to DNA methylation variation was observed, though it was to a smaller extent compared with sample relatedness and cell-type composition. Modest but significant differences in DNA methylation–based estimates between versions were observed, irrespective of the data preprocessing method used. Adjustments for EPIC version or calculation of estimates separately for each version largely mitigated these version-specific discordances. This work emphasizes the importance of accounting for EPIC version differences in research scenarios, especially in meta-analyses and longitudinal studies that require data harmonization across versions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationEpigenomicsHumansFemaleMaleCpG IslandsAdultEpigenesis, GeneticMiddle AgedOligonucleotide Array Sequence Analysis

Autor:innen und Institutionen

  • Edwin S. H. Leong Centre for Healthy Aging, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Centre for Molecular Medicine and Therapeutics and Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • British Columbia Children's Hospital Research Institute, Vancouver, Canada.
  • Department Genes and Environment, Max Planck Institute of Psychiatry, Munich, Germany.
  • International Max Planck Research School for Translational Psychiatry, Munich, Germany.
  • Robert N. Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, NY, USA.

ORCID-Profile: Chaini Konwar, Calen P Ryan, Joanne Whitehead, Toan Khanh Tran, Kim Korinek, Zachary Zimmer, Thomas W McDade, Daniel W Belsky, Elisabeth B Binder, Darina Czamara, Keegan Korthauer, Michael S Kobor

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • Canadian Government | Canadian Institutes of Health Research
  • HHS | NIH | National Institute on Aging
  • HHS | National Institutes of Health
  • HHS | NIH | National Institute of General Medical Sciences
  • Edwin S.H. Leong Centre for Healthy Aging
  • BC Children’s Hospital Research Investigator Grant Award Program

Zitieren

APA

Zhuang, B. C., Jude, M. S., Konwar, C., Yusupov, N., Ryan, C. P., Engelbrecht, H. R., Whitehead, J., Halberstam, A. A., MacIsaac, J. L., Dever, K., Tran, T. K., Korinek, K., Zimmer, Z., Lee, N. R., McDade, T. W., Kuzawa, C. W., Huffman, K. M., Belsky, D. W., Binder, E. B., …, & Kobor, M. S. (2025). Accounting for differences between Infinium MethylationEPIC v2 and v1 in DNA methylation–based tools. Life Science Alliance, 8(9), e202403155. https://doi.org/10.26508/lsa.202403155

Vancouver

Zhuang BC, Jude MS, Konwar C, Yusupov N, Ryan CP, Engelbrecht HR, et al. Accounting for differences between Infinium MethylationEPIC v2 and v1 in DNA methylation–based tools. Life Science Alliance. 2025;8(9):e202403155. doi:10.26508/lsa.202403155

BibTeX
@article{Zhuang2025,
  author = {Zhuang, Beryl C and Jude, Marcia Smiti and Konwar, Chaini and Yusupov, Natan and Ryan, Calen P and Engelbrecht, Hannah-Ruth and Whitehead, Joanne and Halberstam, Alexandra A and MacIsaac, Julia L and Dever, Kristy and Tran, Toan Khanh and Korinek, Kim and Zimmer, Zachary and Lee, Nanette R and McDade, Thomas W and Kuzawa, Christopher W and Huffman, Kim M and Belsky, Daniel W and Binder, Elisabeth B and Czamara, Darina and Korthauer, Keegan and Kobor, Michael S},
  title = {Accounting for differences between Infinium MethylationEPIC v2 and v1 in DNA methylation–based tools},
  journal = {Life Science Alliance},
  year = {2025},
  volume = {8},
  number = {9},
  pages = {e202403155},
  doi = {10.26508/lsa.202403155}
}
Kostenlos starten →